The use of intraovarian injection of autologous platelet rich plasma (PRP) in patients with poor ovarian response and premature ovarian insufficiency.

Herlihy NS, Seli E
Curr Opin Obstet Gynecol. 2022 Jun 1;34(3):133-137. 2022 doi: 10.1097/GCO.0000000000000784


Intra-ovarian injection of PRP is a promising new technology for poor prognosis patients. Rigorous and appropriately controlled clinical trials are warranted to confirm the utility of this treatment for improving patients’ ability to successfully conceive.